Vision Eye Institute Limited (hereinafter referred to as Vision), founded in 2001, is the largest eye care provider in Australia and the first listed chain eye hospital in the world. It owns 15 eye hospitals, 9 advanced ambulatory surgery centers and 6 laser eye surgery centers. With the global first-class medical team and the strict quality and risk management system, Vision is a recognized leader for ophthalmic technology worldwide and the most admired brand.

As a “general practitioner” in ophthalmology, Vision is committed to providing a wide range of professional ophthalmic medical services, including cataract surgery, corneal transplantation, retinal surgery, vitreous injection therapy, laser therapy and so on.

In 2015, Jangho Group acquired and wholly owned Vision. At the end of that year, Vision was delisted from the Australian Stock Exchange. Being an important part of Jangho Group’s development strategy of “double main industry, diversification”, Vision is fully grafted onto the Chinese market and Chinese resources, provide world-class medical technology and services, and effectively promote the development of Jangho’s medical ophthalmic business in China.